Brand name: Odomzo TM
Active ingredients: sonidegib
What it is used for
Odomzo is indicated for the treatment of adult patients with:,- Locally advanced basal cell carcinoma (BCC) who are not amenable to curative surgery or radiation therapy.,- Metastatic BCC
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 42 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Opaque pink capsule,cap imprinted in black ink with NVR, body imprinted in black ink with SONIDEGIB 200MG, containing white powder with granules
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient sonidegib
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems